Education
About Us
Working with TipRanks
Follow Us
Ginkgo Bioworks Holdings, Inc. (DNA)
:DNA
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 227.04M | $ 251.46M | $ 477.71M | $ 313.84M | $ 76.66M |
| Gross Profit | $ 188.49M | $ 197.45M | $ 273.49M | $ 184.15M | $ 61.05M |
| Operating Income | $ -559.76M | $ -864.41M | $ -2.21B | $ -1.83B | $ -137.03M |
| EBITDA | $ -484.39M | $ -821.29M | $ -2.06B | $ -1.81B | $ -108.58M |
| Net Income | $ -547.03M | $ -892.87M | $ -2.10B | $ -1.83B | $ -126.61M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 561.57M | $ 944.07M | $ 1.32B | $ 1.55B | $ 380.80M |
| Total Assets | $ 1.38B | $ 1.67B | $ 2.54B | $ 2.07B | $ 675.15M |
| Total Debt | $ 438.77M | $ 241.77M | $ 442.59M | $ 23.03M | $ 17.00M |
| Net Debt | $ -122.81M | $ -702.30M | $ -873.20M | $ -1.53B | $ -363.80M |
| Total Liabilities | $ 661.39M | $ 568.19M | $ 803.04M | $ 503.61M | $ 205.10M |
| Stockholders' Equity | $ 716.06M | $ 1.10B | $ 1.74B | $ 1.51B | $ 461.38M |
| Cash Flow | |||||
| Free Cash Flow | $ -382.13M | $ -336.30M | $ -304.47M | $ -310.34M | $ -193.65M |
| Operating Cash Flow | $ -319.58M | $ -295.50M | $ -252.20M | $ -253.82M | $ -135.83M |
| Investing Cash Flow | $ -62.24M | $ -80.69M | $ -67.39M | $ -73.26M | $ -67.12M |
| Financing Cash Flow | $ -1.74M | $ -3.22M | $ 95.34M | $ 1.53B | $ 90.32M |